Clinical Trials Browser

Phase 3 × Terminated × Denosumab × Clear all

NCT02129699 2024-09-19

SPLENDOUR

Phase 3 Terminated

595 enrolled 18 charts

Carcinoma, Non-Small-Cell Lung

NCT03408652 2021-10-22

MOSCAR

Phase 3 Terminated

Carcinoma, Renal Cell

NCT01077154 2021-09-28

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

Phase 3 Terminated

4,509 enrolled 25 charts

Breast Neoplasms